Is double inactivation of the Nf1 gene responsible for the development of congenital pseudarthrosis of the tibia associated with NF1?

Journal of Orthopaedic Research

Volumn 30, Issue 10, 2012, Pages 1535-1540

  Lee, Sang Min ^a   Choi, In Ho ^b   Lee, Dong Yeon ^b   Lee, Hye Ran ^b   Park, Moon Seok ^b   Yoo, Won Joon ^b   Chung, Chin Youb ^b   Cho, Tae Joon ^b,c  

^a Eulji University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Children's Hospital   (South Korea)

Author keywords

clonality; congenital pseudarthrosis of the tibia; fibrous hamartoma; loss of heterozygosity; neurofibromatosis type 1

Indexed keywords

NEUROFIBROMIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLONAL VARIATION; CONGENITAL PSEUDARTHROSIS; CONGENITAL PSEUDARTHROSIS OF THE TIBIA; DISEASE COURSE; FEMALE; GENE DELETION; GENE INACTIVATION; HAMARTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; MOLECULAR CLONING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; X CHROMOSOME INACTIVATION;

CHILD; CHILD, PRESCHOOL; FEMALE; GENES, NEUROFIBROMATOSIS 1; HAMARTOMA; HUMANS; INFANT; LOSS OF HETEROZYGOSITY; MALE; PSEUDARTHROSIS; TIBIA;

EID: 84865462133     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22121     Document Type: Article

References (30)

1. Kristiansen LP, Steen H, Terjesen T,. 2003. Residual challenges after healing of congenital pseudarthrosis in the tibia. Clin Orthop Rel Res 414: 228-237. (Pubitemid 37102154)
2. Ippolito E, Corsi A, Grill F, et al. 2000. Pathology of bone lesions associated with congenital pseudarthrosis of the leg. J Pediatr Orthop B 9: 3-10. (Pubitemid 30044013)
3. Cho TJ, Seo JB, Lee HR, et al. 2008. Biologic characteristics of fibrous hamartoma from congenital pseudarthrosis of the tibia associated with neurofibromatosis type 1. J Bone Joint Surg Am 90: 2735-2744.
4. Mariaud-Schmidt RP, Rosales-Quintana S, Bitar E, et al. 2005. Hamartoma involving the pseudarthrosis site in patients with neurofibromatosis type 1. Pediatr Dev Pathol 8: 190-196. (Pubitemid 40895697)
5. Hefti F, Bollini G, Dungl P, et al. 2000. Congenital pseudarthrosis of the tibia: history, etiology, classification, and epidemiologic data. J Pediatr Orthop B 9: 11-15. (Pubitemid 30044014)
6. Crawford AH, Schorry EK,. 2006. Neurofibromatosis update. J Pediatr Orthop 26: 413-423. (Pubitemid 44357075)
7. Kuorilehto T, Nissinen M, Koivunen J, et al. 2004. NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos. J Bone Miner Res 19: 983-989. (Pubitemid 41103455)
8. Leskela HV, Kuorilehto T, Risteli J, et al. 2009. Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression. Bone 44: 243-250.
9. Bollag G, Clapp DW, Shih S, et al. 1996. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 12: 144-148. (Pubitemid 26051293)
10. Cichowski K, Jacks T,. 2001. NF1 tumor suppressor gene function: narrowing the GAP. Cell 104: 593-604. (Pubitemid 32201953)
11. Schindeler A, Little DG,. 2008. Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1). Bone 42: 616-622.
12. Jacks T, Shih TS, Schmitt EM, et al. 1994. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 7: 353-361. (Pubitemid 24204410)
13. Cichowski K, Shih TS, Schmitt E, et al. 1999. Mouse models of tumor development in neurofibromatosis type 1. Science 286: 2172-2176. (Pubitemid 129516295)
14. Upadhyaya M, Han S, Consoli C, et al. 2004. Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors. Hum Mutat 23: 134-146. (Pubitemid 38200604)
15. Li Y, Bollag G, Clark R, et al. 1992. Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69: 275-281.
16. Stevenson DA, Zhou H, Ashrafi S, et al. 2006. Double inactivation of NF1 in tibial pseudarthrosis. Am J Hum Genet 79: 143-148. (Pubitemid 43927385)
17. Ebinger M, Senf L, Wachowski O, et al. 2005. No aberrant methylation of neurofibromatosis 1 gene (NF1) promoter in pilocytic astrocytoma in childhood. Pediatr Hematol Oncol 22: 83-87. (Pubitemid 40054026)
18. Lopez Correa C, Brems H, Lazaro C, et al. 1999. Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions. Hum Mutat 14: 387-393. (Pubitemid 29529543)
19. Xu GF, Nelson L, O'Connell P, et al. 1991. An Alu polymorphism intragenic to the neurofibromatosis type 1 gene (NF1). Nucleic Acids Res 19: 3764.
20. Lazaro C, Gaona A, Xu G, et al. 1993. A highly informative CA/GT repeat polymorphism in intron 38 of the human neurofibromatosis type 1 (NF1) gene. Hum Genet 92: 429-430. (Pubitemid 23323616)
21. Diaz-Cano SJ, Blanes A, Wolfe HJ,. 2001. PCR techniques for clonality assays. Diagn Mol Pathol 10: 24-33. (Pubitemid 32180180)
22. Thouin MM, Giron JM, Hoffman EP,. 2003. Detection of nonrandom X chromosome inactivation. Curr Protoc Hum Genet Chapter 9: Unit 9.7. http://www.currentprotocols.com/WileyCDA/CPUnit/refId-hg0907.html
23. Sharp A, Robinson D, Jacobs P,. 2000. Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genet 107: 343-349.
24. Boudewijns M, van Dongen JJ, Langerak AW,. 2007. The human androgen receptor X-chromosome inactivation assay for clonality diagnostics of natural killer cell proliferations. J Mol Diagn 9: 337-344. (Pubitemid 47305070)
25. Allen RC, Zoghbi HY, Moseley AB, et al. 1992. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51: 1229-1239. (Pubitemid 23001082)
26. Alwan S, Tredwell SJ, Friedman JM,. 2005. Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)? Clin Genet 67: 378-390. (Pubitemid 40561488)
27. Yu X, Chen S, Potter OL, et al. 2005. Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning. Bone 36: 793-802. (Pubitemid 40616014)
28. Serra E, Puig S, Otero D, et al. 1997. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet 61: 512-519. (Pubitemid 27418392)
29. McLaughlin M, Jacks T,. 2002. Thinking beyond the tumor cell: Nf1 haploinsufficiency in the tumor environment. Cancer cell 1: 408-410. (Pubitemid 41039119)
30. Busque L, Mio R, Mattioli J, et al. 1996. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood 88: 59-65. (Pubitemid 26230671)